Drug Development Executive

Drug Development Executive

Share this post

Drug Development Executive
Drug Development Executive
Targeting Synovitis in Hand Osteoarthritis: A Review of Treatment Efficacy and Future Directions

Targeting Synovitis in Hand Osteoarthritis: A Review of Treatment Efficacy and Future Directions

Eswar Krishnan, MD's avatar
Eswar Krishnan, MD
Jun 01, 2025
∙ Paid

Share this post

Drug Development Executive
Drug Development Executive
Targeting Synovitis in Hand Osteoarthritis: A Review of Treatment Efficacy and Future Directions
Share

Clinical Question: In patients with hand osteoarthritis (OA), do anti-inflammatory treatments effectively reduce symptoms and modify disease progression?

Bottom Line: Observational studies consistently show synovitis is common in hand OA and linked to both pain and disease progression, suggesting inflammation is a viable treatment target. However, clinic…

Keep reading with a 7-day free trial

Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Eswar Krishnan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share